NHS Framework Agreement for the supply of Recombinant Factor IX products for the treatment of Haemophilia B
NHS Englandgoods
What the buyer wrote
NHS National Framework Agreement for the supply of Recombinant Factor IX products for the treatment of Haemophilia B. The framework will commence on 1st March 2019 for a period of 24 months until 28th February 2021, with options to extend up to a further 24 month.
Bid for this and lost? There is a short window in which the decision can be questioned.
Awarded to
Details
- What the buyer calls it
- NHS Framework Agreement for the supply of Recombinant Factor IX products for the treatment of Haemophilia B
- How they are buying
- Advertised, open to anyoneAny supplier could bid without being invited first.
- Type
- goods
- Suitable for small firms
- The buyer says yes. What that is worth
- Work starts
- 1 Mar 2019
- Work ends
- 28 Feb 2021
- Kind of work
- Health and social care
Who the buyer named
Natalie Hailwood was the named contact on this notice.